The use of anticoagulation therapy at diagnosis of left-sided infective endocarditis may increase the risk for intracranial hemorrhage, especially when combined with antiplatelet therapy.

Overall, 5.7 percent of participants with MCI had one-year risk for any indication for anticoagulant and thrombolytic drugs.

The risk of bleeding events was increased in patients receiving anticoagulation therapy with either ASA or DAPT. Postoperative anticoagulant therapy and early use of heparin were independently ...

The noninferiority trial of patients at risk for both bleeding and stroke, in a surprise turn, found standard care to be superior.

Untreated atrial fibrillation carries an approximately 3 to 5% annual risk of ischemic stroke. Long-term oral anticoagulation therapy decreases this risk to 1.7% with warfarin and to 1.5% with ...

Please provide your email address to receive an email when new articles are posted on . Anticoagulant therapy before GCA diagnosis had a protective effect against cranial ischemic complications. Risk ...

Favorable safety shown in secondary prevention for acute venous thromboembolism ...

CHICAGO -- For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban (Eliquis) was just as effective as a higher dose -- and safer, the ...

18F-FET-PET hypermetabolic brain lesions: A correlation study to MRI and histopathologic findings. Background: Venous thromboembolic events (VTE) are common in glioblastoma (GBM) patients, and ...

MADRID -- Stopping oral anticoagulation after successful ablation for atrial fibrillation (AF, Afib) improved outcomes for patients without documented recurrence, the randomized ALONE-AF trial showed.